IP Library Granted Patent US 9,056,887
Granted Patent B2
US 9,056,887 · App. 13/556,513 · Granted Jun 16, 2015

Minor groove binder phosphoramidites and methods of use

Inventors: Alexei Vorobiev (Redmond, WA); Eugeny A. Lukhtanov (Bothell, WA)
Assignee: Elitech Holding B.V.
C07H21/00C07F9/65068C07F9/65583C07F9/6561C07D235/18C07D403/04C07D519/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,056,887
App. No.
13/556,513
Granted
Jun 16, 2015
Kind
B2
Abstract

Minor groove binder phosphoramidites having the formula M-L-PA, wherein M is a minor groove binder comprising a protected heteroaromatic amine, L is a linker, and PA is a phosphoramidite group, have been synthesized. Preferred methods of synthesis include synthesizing a minor groove binder intermediate containing a transiently protected hydroxyl group, protecting heteroaromatic amines of the corresponding minor groove binder intermediate as carbamate intermediates, reacting the carbamate intermediate to remove the transient protecting group to yield carbamate-protected minor groove binder agent as an intermediate with a free hydroxyl group, and converting the intermediate with a free hydroxyl group to the desired minor groove binder phosphoramidite. These minor groove binder phosphoramidites are useful in the preparation of oligonucleotide conjugates, particularly those for use as probes and primers. In preferred methods, an oligonucleotide sequence is synthesized using nucleoside phosphoramidites and the minor groove binder phosphoramidite is incorporated into the oligonucleotide sequence to form a protected oligonucleotide-minor groove binder conjugate. Then, deprotection produces the oligonucleotide-minor groove binder.

Claims (23)

1. A minor groove binder phosphoramidite having Formula II or Formula III:

wherein R 1 and R 2 are each independently PG, L, C 1-8 alkyl, C 1-8 heteroalkyl, protected C 1-8 heteroalkyl, —(CH 2 CH 2 O) y CH 2 CH 3 where y is 1 to 8, or R 1 and R 2 form a 5 or 6 member ring structure containing 0, 1 or 2 hetero atoms selected from O, S and N;

n is 1 to 4;

L is a linker which is an acyclic, a cyclic, or an aromatic divalent moiety or a combination thereof, having from 4 to 50 atoms, exclusive of hydrogens that fill available valences, selected from a group consisting of C, N, O, P, and S;

PG is a protecting group; and

PA is a phosphoramidite group.

2. The minor groove binder phosphoramidite of claim 1 having the following formula:

3. A method for synthesizing an oligonucleotide-minor groove binder conjugate, comprising the steps of:

(a) synthesizing an oligonucleotide sequence with nucleoside phosphoramidites;

(b) incorporating the minor groove binder phosphoramidite of claim 1 into the oligonucleotide sequence to form a protected oligonucleotide-minor groove binder conjugate; and

(c) deprotecting the protected oligonucleotide-minor groove binder conjugate to form an oligonucleotide-minor groove binder conjugate.

4. A minor groove binder phosphoramidite having Formula IV or V:

wherein R 1 is L, C 1-8 alkyl, C 1-8 heteroalkyl, protected C 1-8 heteroalkyl, —(CH 2 CH 2 O) y CH 2 CH 3 where y is 1 to 8, or substituted or unsubstituted aryl or heteroaryl;

n is 1 to 4;

L is a linker which is an acyclic, a cyclic, or an aromatic divalent moiety or a combination thereof, having from 4 to 50 atoms, exclusive of hydrogens that fill available valences, selected from a group consisting of C, N, O, P, and S;

PG is a protecting group; and

PA is a phosphoramidite group.

5. The minor groove binder phosphoramidite of claim 4 having the following formula:

6. The minor groove binder phosphoramidite of claim 4 having the following formula:

7. A method for synthesizing an oligonucleotide-minor groove binder conjugate, comprising the steps of:

(a) synthesizing an oligonucleotide sequence with nucleoside phosphoramidites;

(b) incorporating the minor groove binder phosphoramidite of claim 4 into the oligonucleotide sequence to form a protected oligonucleotide-minor groove binder conjugate; and

(c) deprotecting the protected oligonucleotide-minor groove binder conjugate to produce an oligonucleotide-minor groove binder conjugate.

Assignments (4)
NUNC PRO TUNC ASSIGNMENT Recorded Jan 11, 2022
From: ELITECHGROUP, INC.
To: ELITECHGROUP MDX LLC
Reel/Frame 058615/0341 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2019
From: ELITECHGROUP B.V.
To: ELITECHGROUP, INC.
Reel/Frame 048078/0553 →
CHANGE OF NAME Recorded Mar 10, 2017
From: ELITECH HOLDING BV
To: ELITECHGROUP B.V.
Reel/Frame 041974/0867 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2012
From: VOROBIEV, ALEXEI; LUKHTANOV, EUGENY A.
To: ELITECH HOLDING B.V.
Reel/Frame 029017/0900 →
Continuity (2)
Provisional Application 61511733 · Jul 26, 2011
Related Publication 20130030166A1 · Jan 31, 2013